• WADA publishes 2025 Prohibited List
  
• WADA responds to questions received from New York Times related to clenbuterol cases 15 June 2024
  
• WADA Publishes 2022 Testing Figures Report - 3 April 2024
  
• WADA announces I&I project results at Annual Symposium
  
• New Year message from WADA President and Director General - 9 January 2024
  
• WADA publishes 2024 Prohibited List - 28 September 2023
  
• AIU’S TESTING FOCUS FOR BUDAPEST 23 – PROTECTING THE PODIUM AND BLOOD-COLLECTION INNOVATION - 19 AUGUST 2023
  
• Spotlight - Program Development - 27 July 2023
  
• WADA and POLADA contribute to successful police raid and steroid seizure - 28 June 2023
  
• WADA publishes 2022 Code Compliance Annual Report - 27 June 2023
  
• WADA delivers worksh-op as part of European I&I project - 31 March 2023
  
• WADA announces inaugural Ethics Officer - 30 March 2023
  
• WADA launches Initial Human Rights Impact Assessment - 7 March 2023
  
• WADA confirms non-compliance of the IFBB - 17 October 2022
  
• WADA publishes 2023 Prohibited List - 29 September 2022
  
• WADA President opens Global Education Conference in Sydney - 20 September 2022
  
• Athlete Engagement: The ‘Be Athlete Centered’ priority in action
  
• WADA calls on global anti-doping community to Play True for Peace
  
• WADA publishes IO Team Reports from 2020 Tokyo Summer Games
  
• WADA issues Anti-Doping Rule Violations Report for 2019
  
• WADA publishes 2022 Prohibited List 2021.09.30
  
• WADA strengthens anti-doping system through ADAMS re-build
  
• WADA signs MOU with the Central European Anti-Doping Organization
  
• WADA’s 2021 Play True Day Campaign reaches over 87 million people
  
• WADA celebrates ‘Play True Day 2021’
  
• Pre-games anti-doping activities for Beijing 2022 Olympic Games
  
• Save the date for Play True Day 2021
  
• WADA reinstates Helsinki Laboratory accreditation
  
• Stakeholder consultation process for new Technical Document on DBS
  
• Guidance Note for ADOs regarding Substances of Abuse under 2021 Code
  
• The 2021 World Anti-Doping Code and International Standards are now in force
  
• Long-Term Storage Programme of the Tokyo 2020 Pre-Games Samples
  
• WADA releases updated Guidelines to complement the 2021 ISTUE
  
• WADA statement on CAS decision to declare RUSADA as non-compliant
  
• WADA issues Call for Proposals for 2021 Scientific Research Grants
  
• The new Anti-Doping Education and Learning (ADEL)
  
• WADA publishes updated Therapeutic Use Exemption Application Form
  
• WADA's 2019 Testing Figures Report: for ADO review
  
• Lebanon becomes 191st country to ratify UNESCO Anti-Doping Convention
  
• Changes to 2021 World Anti-Doping Code impacting Doping Control activities
  
• How WADA helps whistleblowers to ‘Speak Up!’
  
• WADA publishes 2019 Annual Report themed ‘Towards a World of Clean Sport’
  
• WADA launches stakeholder consultation regarding 2021 Technical Letters
  
• WADA issues 2021 International Standard for Laboratories
  
• WADA strengthens Social Science Research with new strategy
  
• WADA postpones 29 September webinar regarding ISL to 13 October
  
• WADA publishes revised Technical Letter TL22: Ethylmorphine
  
• WADA issues revised 2021 Privacy Standard
  
• WADA boosts investigations capabilities with new compliance team
  
• WADA to host six additional ‘live’ webinars in October
  
• WADA welcomes decision of French court in Diack case
  
• WADA publishes new Guidelines for Education
  
• WADA Executive Committee paves the way for further governance reforms
  
• WADA calls for unity to protect clean athletes
  
• WADA statement on the dismissal of RUSADA’s Director General
  
• WADA launches Stakeholder Perceptions Survey
  
• WADA publishes ‘live’ webinar schedule for September
  
• WADA invites applications for research projects on the development of DBS testing
  
• WADA publishes final version of Athletes’ Anti-Doping Rights Act
  
• WADA statement on investigation into the IWF
  
• WADA reminds Code Signatories to revise their anti-doping rules for 2021
  
• WADA fully reinstates accreditation of Salt Lake City Laboratory
  
• WADA study: No meaningful link between TUEs and Olympic medals
  
• WADA Publishes 2019 Monitoring Program Figures
  
• WADA launches stakeholder consultation for the 2021 Prohibited List
  
• Mauritania becomes 189th country to ratify UNESCO Anti-Doping Convention
  
• Consultation process regarding Technical Letter on Ethylmorphine
  
• WADA removes ITF-Austria from non-compliant list
  
• WADA publishes membership of Standing Committees for 2020
  
• WADA publishes Independent Observer Team Report from 2019 Pan Am Games
  
• WADA updates COVID-19 guidance for Anti-Doping Organizations
  
• WADA statement on Tokyo Olympic and Paralympic Games postponement
  
• WADA issues ADO guidance in connection with COVID-19